Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of the muscarinic M 1 receptor antagonist biperiden on cognition in medication free subjects with psychosis
Claudia Vingerhoets, Geor Bakker, J. Van Dijk, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 9, pp. 854-864
Closed Access | Times Cited: 20

Showing 20 citing articles:

Anticholinergic Drugs in Geriatric Psychopharmacology
Jorge López‐Álvarez, Julia Sevilla‐Llewellyn‐Jones, Luis Agüera-Ortíz
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 111
A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia
Brian Dean, Geor Bakker, Hiroki R. Ueda, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 26
Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All?
Daniel C. Javitt
American Journal of Psychiatry (2025) Vol. 182, Iss. 3, pp. 237-239
Closed Access | Times Cited: 1
DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens
Anton M. Lakstygal, Tatiana O. Kolesnikova, Sergey L. Khatsko, et al.
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 5, pp. 2144-2159
Closed Access | Times Cited: 64
Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis
Geor Bakker, Claudia Vingerhoets, Daphne Boucherie, et al.
NeuroImage Clinical (2018) Vol. 18, pp. 713-719
Open Access | Times Cited: 38
Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder
Paul Cumming, Anissa Abi‐Dargham, Gerhard Gründer
Behavioural Brain Research (2020) Vol. 398, pp. 113004-113004
Open Access | Times Cited: 32
Cholinergic Receptor Muscarinic 1 Co-Localized with Mitochondria in Cultured Dorsal Root Ganglion Neurons, and Its Deletion Disrupted Mitochondrial Ultrastructure in Peripheral Neurons: Implications in Alzheimer’s Disease
Mohammad Golam Sabbir
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 1, pp. 247-264
Closed Access | Times Cited: 2
Cholinergic models of memory impairment in animals and man: scopolamine vs. biperiden
Arjan Blokland
Behavioural Pharmacology (2022) Vol. 33, Iss. 4, pp. 231-237
Closed Access | Times Cited: 9
A novel method for the therapeutic drug monitoring of biperiden in plasma by GC-MS using salt-assisted liquid–liquid microextraction
Aykut Kul, Olcay Sağırlı
Clinica Chimica Acta (2023) Vol. 543, pp. 117322-117322
Closed Access | Times Cited: 4
Biperiden Selectively Impairs Verbal Episodic Memory in a Dose- and Time-Dependent Manner in Healthy Subjects
Laura Borghans, Anke Sambeth, Arjan Blokland
Journal of Clinical Psychopharmacology (2019) Vol. 40, Iss. 1, pp. 30-37
Open Access | Times Cited: 9
Effects of Anticholinergic Burden on Verbal Memory Performance in First-Episode Psychosis
Agnès Belkacem, Katie M. Lavigne, Carolina Makowski, et al.
The Canadian Journal of Psychiatry (2023) Vol. 68, Iss. 12, pp. 894-903
Open Access | Times Cited: 3
Influence of muscarinic M1 receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study
Claudia Vingerhoets, Geor Bakker, Anouk Schrantee, et al.
Psychiatry Research Neuroimaging (2019) Vol. 290, pp. 5-13
Closed Access | Times Cited: 7
Neuropsychological Findings in Adults with Triple X Syndrome
Maarten Otter, Bea Campforts, Connie TRM Stumpel, et al.
(2022)
Open Access | Times Cited: 5
Mnemonic and behavioral effects of biperiden, an M1-selective antagonist, in the rat
Anna Popelíková, Štěpán Bahník, Veronika Lobellová, et al.
Psychopharmacology (2018) Vol. 235, Iss. 7, pp. 2013-2025
Closed Access | Times Cited: 3
An exploratory, randomised, crossover study to investigate the effect of nicotine on cognitive function in healthy adult smokers who use an electronic cigarette after a period of smoking abstinence
Harry J. Green, Olivia K. O’Shea, Jack Cotter, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access
Anti-Cholinergic Derangement of Cortical Metabolism on 18F-FDG PET in a Patient with Frontotemporal Lobar Degeneration Dementia: A Case of the TREDEM Registry
Maurizio Gallucci, Claudia Pallucca, Maria Elena Di Battista, et al.
Journal of Alzheimer s Disease (2020) Vol. 74, Iss. 4, pp. 1107-1117
Closed Access | Times Cited: 2
Acetylcholine Imaging in Psychosis
Claudia Vingerhoets, Jan Booij, Thérèse van Amelsvoort
Springer eBooks (2020), pp. 525-539
Closed Access | Times Cited: 2
The antimuscarinic agent biperiden selectively impairs recognition of abstract figures without affecting the processing of non‐words
Monika Tóth, Anke Sambeth, Arjan Blokland
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 2
Open Access | Times Cited: 2
Effects of Anticholinergic Burden on Verbal Memory Performance in First-Episode Psychosis
Agnès Belkacem, Katie M. Lavigne, Carolina Makowski, et al.
(2023)
Open Access
Processing of novelty and familiarity in the aging brain
Monika Tóth
(2022)
Open Access
Page 1

Scroll to top